At a glimpse
ETAP-Lab is a French preclinical CRO with over 30 years' expertise in derisking research & advancing drug development for pharmaceutical and biotech companies.
Our expertise covers dermatological, cardiological, neurovascular and neurological diseases thanks to our dedicated research labs.
Our range of services
• A portfolio of over 60 tried-and-tested in vitro and in vivo reference models.
• Proof of concept & pharmacological experiments
• Efficacy & safety studies
Working with us
• Personalized & expert advisory
• Tailor-made & flexible study designs Constant innovation & validated methods
• Technical expertise & production facilities
• Advanced technological capabilities
• Robustness, Translational-approach, & Expertise
• ISO9001 quality approach
Our unique approach
By respecting rodent chronobiology and natural behaviors, ETAP-Lab proposes research models with added translational value.
Our experts aim to provide our clients with the most relevant data using state-of-the-art techniques and imaging, still to offer better predictability of compounds' efficacy.
Tailored services
Beyond expertise, our flexible and human-sized organization can design and operate tailored drug efficacy studies to fit client's needs.
Focus on our 4 dedicated labs of excellence
• Dermatology lab: portfolio of original in vivo rodent models such as psoriasis, atopic dermatitis, wound healing, ischemic ulceration & skin grafting…
• Cardiology lab: SYNCROSOME's range of services in cardiovascular & respiratory diseases models such as HFrEF, HFpEF & PAH. LinkedIn Page: https://www.linkedin.com/company/syncrosome
• Neurovascular/Stroke lab: STROK@LLIANCE, leader in the field of preclinical stroke research, offering Ischemic Stroke, Hemorrhagic Stroke & Thrombo-embolic stroke models.
• Neurology lab: from in vitro to in vivo solutions, for Proteinopathies with our own oligomers (AD's, PD's) & psychopharmacology.
Check out our portfolio of models!
Company Details
- Employees
- 36
- Founded
- -
- Address
- 13, Rue Du Bois De La Champelle, Vandoeuvre-Lès-Nancy,54500,france
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- etap-lab.com
- Keywords
- Dermatology, Neurosciences, Stroke, Preclinical pharmacology, in vitro models, animal model, Inflammatory diseases, Neurodegenerative diseases, Neurology, Cardiorespiratory, in vivo drug efficacy study, Parkinson, Alzheimer, protheinopathy, Metabolic disease, Cardiac disease, Preclinical CRO, Heart failure, Drug testing.
- HQ
- Vandoeuvre-lès-Nancy
Etap-Lab - Preclinical Efficacy Cro Questions
Etap-Lab - Preclinical Efficacy Cro's website is etap-lab.com
Etap-Lab - Preclinical Efficacy Cro's LinkedIn profile is https://fr.linkedin.com/company/etap-lab
Etap-Lab - Preclinical Efficacy Cro has
36 employees.
View email and phone details for 36
employees at Etap-Lab - Preclinical Efficacy Cro.
Etap-Lab - Preclinical Efficacy Cro's industry is
Research Services
Etap-Lab - Preclinical Efficacy Cro's top competitors are
Afssi Sciences De La Vie,
Biotechni Sas,
Biohive,
Syncrosome - Cardiovascular Preclinical Expert,
Biovalley France,
Ascnd (Ex C2i Santé),
Alvéole,
Centaur Clinical Cro,
Preventech Consulting,
4dcell.
Etap-Lab - Preclinical Efficacy Cro's categories are Research Services
Etap-Lab - Preclinical Efficacy Cro's founding year is 1991
